is projected to reach USD 5.31 billion by 2027 according to a new study conducted by Polaris Market Research the market is anticipated to register a
CAGR of 5.1% from 2020 to 2027. An increasingly aging population has gradually resulted in a rise of cases of lewy body dementia, which is one of the primary factors driving the growth of the global market. A higher number of dementia cases in developed countries are creating strong demand for effective drugs and leading manufacturers bringing new products tailored to cure the disease are expected to fuel significant demand for dementia treatment in the global market. An increased government effort to spread awareness regarding the treatment for lewy body dementia and the rising prevalence of brain-related disorders is foreseen to strengthen the market growth.